SQShuiwei Qiu

Shuiwei Qiu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shuiwei Qiu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Quansheng Xing

    Women & Children's Hospital Qingdao University Qingdao China

    2 shared publications
  • Dingliang Lv

    Affiliation Cardiothoracic surgery, the Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, China

    1 shared publication
  • JiangDong Sun

    Qingdao University, 308 Ningxia Road,Qingdao, Shandong Province, China, Qingdao, Shandong, 266071, CHINA

    1 shared publication
  • Lin Chen

    Affiliation Cardiothoracic surgery, the Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, China

    1 shared publication
  • Min Zhou

    Affiliation Cardiothoracic surgery, the Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, Zhejiang, China

    1 shared publication
  • ShanShan Wang

    Qingdao University, 308 Ningxia Road,Qingdao, Shandong Province, China, Qingdao, Shandong, 266071, CHINA

    1 shared publication

Latest Publications

  • Open Access

    The association between cadmium exposure and lung cancer risk: A protocol for systematic review and meta-analysis

    by Lin Chen, Min Zhou, Dingliang Lv, Shuiwei Qiu

    Background: Cadmium (Cd), a toxic heavy metal, is classified as a human carcinogen by the International Agency for Research on Cancer (IARC). Epidemiological studies suggested a potential link between cadmium exposure and lung cancer risk, but evidence has remained inconsistent, particularly regarding differences between occupational and general populations. This protocol will outline a systematic review and meta-analysis to quantify the association between cadmium exposure (via blood, urine, hair, or environmental samples) and lung cancer risk. Methods: This study protocol will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (PRISMA-P) guidelines. A comprehensive search of PubMed, Embase, Web of Science, Medline, and Cochrane databases will identify observational studies published from inception to December 2024. Two reviewers will independently screen studies, extract data, and assess the quality of included using the Newcastle-Ottawa Scale (NOS). We will harmonize data to calculate pooled relative risks (RRs) with 95% confidence intervals (CIs). Random-effects model is anticipated for high-heterogeneous results, while fixed-effects model will be adopted for low- heterogeneous results. Sub-group analyses (e.g., population type (general/occupational), geographic region, year of publication), sensitivity analyses, and assessments of publication bias (Egger’s test, funnel plots) will be conducted to ensure the robustness and reliability of the findings. The analyses will be conducted via RevMan 5.3 and STATA 15 software. Discussion: This protocol will guide the standard process of the systematic review, providing synthesized evidence on the short-, and long-term effect of cadmium on lung risk in general and occupational populations. Conclusion: This systematic review and meta-analysis will provide synthesized evidence regarding cadmium exposure with lung cancer risk in both occupational and general populations. The evidence obtained in this study can inform the public and the policy-making bodies. Register on PROSPERO: CRD42024527248.


  • Open Access

    Digital light 3D printing of artificial bone with star-shaped polycaprolactone-based polyurethane acrylate

    by Xinmeng Yang, Shuiwei Qiu, Zhanhui Du, Quansheng Xing

    Advanced medical materials and manufacturing technologies are highly in demand in artificial bones. Herein, a four-arm star-shaped polycaprolactone polyurethane acrylate (FPCLA) was designed and synthesized. The photosensitive character of FPCLA contributed to the rapid prototyping and personalized customization under digital light processing (DLP) 3D printing technology. The FPCLA was prepared by introducing unsaturated double bonds into polycaprolactone tetraethyl alcohol (PCLT). We characterized the physico-chemical properties of the material through FTIR, H-NMR, GPC, DSC and SEM. Cell behaviors on material were observed in vitro. In addition, we employed a DLP 3D printer to evaluate the feasibility of FPCLA to fabricate artificial bone model. The photocuring star polycaprolactone was confirmed in detail by detection method. SEM analyses demonstrated that FPCLA has good tenacity. The material can be used to fabricated artificial bone with a diameter of 3.02 mm at its narrowest by DLP 3D printing technology. The cell survival rates of CCK-8 and Live/Dead fluorescence staining experiments were both above 90%, which indicated safety and feasibility of such new-generation artificial bone made of synthetic polymers.


  • Open Access

    Poly (butylene adipate-co-terephthalate)/Sodium alginate blends have superior characteristics and can be used to fabricate vascular stents

    by ShuiWei Qiu, YingHui Xia, JiangDong Sun, ShanShan Wang, QuanSheng Xing

    To investigate the physical properties and in vitro biocompatibility of Poly (butylene adipate-co-terephthalate) and Sodium alginate (PBAT/SA) melt blending, as well as feasibility of using PBAT/SA blending materials to fabricate vascular stents through 3D printing technology. PBAT/SA composites were prepared by melt blending, and then related physical properties were assessed through FTIR, SEM, DSC, and water contact angle tests. The effects of the PBAT/SA blend on cell morphology, ROS, apoptosis, and cell proliferation were analyzed in vitro. In addition, we employed a 4-axis 3D printer to evaluate the feasibility of using PBAT/SA blend materials to fabricate vascular stents. We successfully prepared PBAT/SA melt blended materials. FTIR and SEM analyses demonstrated that PBAT and SA were compatible, while DSC data confirmed that the addition of SA improved the thermal properties of PBAT. Besides, water contact angle analysis showed that SA improved the hydrophilicity of PBAT. In addition, we successfully fabricated PBAT/SA vascular stent using 4-axis 3D printing technology. Our data showed that PBAT and SA are compatible, and the addition of SA enhances the thermal properties and hydrophilicity of PBAT. In addition, PBAT/SA blend materials can be fabricated into vascular stents using 4-axis 3D printing technology.